Top compounds associated with response to MAPT


Feature Type Standardized
Nominal ANOVA
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.15 2e-06
mRNA YM201636 GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.29 3e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.17 6e-06
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.14 8e-06
mRNA PF-562271 GDSC1000 pan-cancer AAC -0.16 8e-06
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.17 8e-06
Download CSV